Welcome to PrEP Watch, a comprehensive
information source on pre-exposure prophylaxis for HIV prevention
Pre-exposure prophylaxis (PrEP) refers to an experimental HIV-prevention strategy that would use anti-retrovirals to protect HIV-negative people from HIV infection. PrEP is not proven to work; in the strategy that is currently being tested, HIV-negative people would take a single drug, or a combination of drugs, daily in hopes that this would protect them against HIV infection. Along with AIDS vaccines and microbicides, PrEP is one of the experimental HIV-prevention strategies being tested in clinical trials today.
PrEP Watch features a regularly-updated table of planned and ongoing trials as well as current information including scientific findings, advocacy documents, and meeting reports. More background on many related topics such as prevention-trial ethics and standard of care can be found at the AIDS Vaccine Clearinghouse.
